These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17604415)

  • 1. Standardised MedDRA queries: their role in signal detection.
    Mozzicato P
    Drug Saf; 2007; 30(7):617-9. PubMed ID: 17604415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semantic distance-based creation of clusters of pharmacovigilance terms and their evaluation.
    Dupuch M; Grabar N
    J Biomed Inform; 2015 Apr; 54():174-85. PubMed ID: 25659451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications.
    Chang LC; Mahmood R; Qureshi S; Breder CD
    PLoS One; 2017; 12(6):e0178104. PubMed ID: 28570569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the standardised MedDRA® queries for case retrieval in the French spontaneous reporting database.
    Géniaux H; Assaf D; Miremont-Salamé G; Raspaud B; Gouverneur A; Robinson P; Pariente A; Salvo F
    Drug Saf; 2014 Jul; 37(7):537-42. PubMed ID: 24942754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Critical Evaluation of Safety Signal Analysis Using Algorithmic Standardised MedDRA Queries.
    Tieu C; Breder CD
    Drug Saf; 2018 Dec; 41(12):1375-1385. PubMed ID: 30112728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grouping pharmacovigilance terms with semantic distance.
    Dupuch M; Lerch M; Jamet A; Jaulent MC; Fescharek R; Grabar N
    Stud Health Technol Inform; 2011; 169():794-8. PubMed ID: 21893856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA).
    Brown EG
    Drug Saf; 2003; 26(3):145-58. PubMed ID: 12580645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MedDRA Labeling Groupings to Improve Safety Communication in Product Labels.
    Große-Michaelis I; Proestel S; Rao RM; Dillman BS; Bader-Weder S; Macdonald L; Gregory W
    Ther Innov Regul Sci; 2023 Jan; 57(1):1-6. PubMed ID: 35939205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploitation of semantic methods to cluster pharmacovigilance terms.
    Dupuch M; Dupuch L; Hamon T; Grabar N
    J Biomed Semantics; 2014; 5():18. PubMed ID: 24739596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions.
    Bousquet C; Lagier G; Lillo-Le Louët A; Le Beller C; Venot A; Jaulent MC
    Drug Saf; 2005; 28(1):19-34. PubMed ID: 15649103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MedDRA and pharmacovigilance: a complex and little-evaluated tool.
    Prescrire Int; 2016 Oct; 25(175):247-250. PubMed ID: 30645835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Method for Retrieval of Adverse Event Terms in Clinical Trial Databases Using Standardised MedDRA Queries.
    Breder CD
    Pharmaceut Med; 2016 Apr; 30(2):103-108. PubMed ID: 27274655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
    Pearson RK; Hauben M; Goldsmith DI; Gould AL; Madigan D; O'Hara DJ; Reisinger SJ; Hochberg AM
    Int J Med Inform; 2009 Dec; 78(12):e97-e103. PubMed ID: 19230751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The medical dictionary for regulatory activities (MedDRA).
    Brown EG; Wood L; Wood S
    Drug Saf; 1999 Feb; 20(2):109-17. PubMed ID: 10082069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADEpedia-on-OHDSI: A next generation pharmacovigilance signal detection platform using the OHDSI common data model.
    Yu Y; Ruddy KJ; Hong N; Tsuji S; Wen A; Shah ND; Jiang G
    J Biomed Inform; 2019 Mar; 91():103119. PubMed ID: 30738946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comprehensive Methodology to Systematically Identify Drug Hypersensitivity and Anaphylactic Reactions in Clinical Trial Databases.
    Xavier H; Hara I; Ottesen LH; Verheijen RB; Ghiorghiu D; Morgan C
    Pharmaceut Med; 2020 Oct; 34(5):335-345. PubMed ID: 32975782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an ontological resource for pharmacovigilance.
    Jaulent MC; Alecu I
    Stud Health Technol Inform; 2009; 150():522-6. PubMed ID: 19745366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OntoADR a semantic resource describing adverse drug reactions to support searching, coding, and information retrieval.
    Souvignet J; Declerck G; Asfari H; Jaulent MC; Bousquet C
    J Biomed Inform; 2016 Oct; 63():100-107. PubMed ID: 27369567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automatic generation of MedDRA terms groupings using an ontology.
    Declerck G; Bousquet C; Jaulent MC
    Stud Health Technol Inform; 2012; 180():73-7. PubMed ID: 22874155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MedDRA® automated term groupings using OntoADR: evaluation with upper gastrointestinal bleedings.
    Souvignet J; Asfari H; Lardon J; Del Tedesco E; Declerck G; Bousquet C
    Expert Opin Drug Saf; 2016 Sep; 15(9):1153-61. PubMed ID: 27348725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.